Humacyte, Inc. (HUMA)
0.9601
-0.05
(-4.94%)
USD |
NASDAQ |
Dec 31, 14:59
Humacyte Research and Development Expense (Quarterly): 17.27M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 5.098M |
| Rockwell Medical, Inc. | 0.00 |
| Nuwellis, Inc. | 0.603M |
| Salarius Pharmaceuticals, Inc. | 0.0618M |
| Biomea Fusion, Inc. | 14.40M |